Patients with human papillomavirus (HPV+)–associated head and neck cancer (HNC) show
significantly improved survival outcome compared with those with HPV-negative (HPV−) …

Approximately 25% of head and neck squamous cell carcinoma (HNSCC) worldwide are
associated with high-risk human papillomaviruses (HPV). HPV-positive HNSCCs have a …

Although development of head and neck squamous cell carcinomas (HNSCCs) is commonly
linked to the consumption of tobacco and alcohol, a link between human papillomavirus …

To obtain information on the incidence and the clinical significance of infection with various
types of the human papillomavirus (HPV) in cancer of the uterine cervix, we retrospectively …

As the detection rate of HPV‐DNA in anal carcinoma commonly exceeds 90%, a comparison
between sole HPV‐positive and HPV‐negative cancers with respect to treatment response …

Purpose: Human papillomavirus (HPV) is linked with a subset of head and neck squamous
cell carcinomas (HNSCC). HPV-positive HNSCCs show a better prognosis than HPV …

Intrinsic radiosensitivity is an important factor underlying radiotherapy response, but there is
no method for its routine assessment in human tumours. Gene signatures are currently …

More than one‐third of patients with locally advanced cervical cancer do not respond to
chemoradiation therapy (CRT). We aimed to characterize the transcriptional landscape of …

The role of human papillomavirus (HPV) in anal squamous cell carcinoma (ASCC)
carcinogenesis has been clearly established, involving the expression of viral oncoproteins …

PURPOSE: Patients with oropharyngeal squamous cell carcinoma (OSCC) whose disease
is associated with high-risk human papillomavirus (HPV) infection have a significantly better …